1. Home
  2. ANL vs LOMA Comparison

ANL vs LOMA Comparison

Compare ANL & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.62

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Logo Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

LOMA

Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

SELL

Current Price

$9.37

Market Cap

1.2B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
ANL
LOMA
Founded
2004
1926
Country
Singapore
Argentina
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
1.2B
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
ANL
LOMA
Price
$10.62
$9.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
★ $29.50
$14.30
AVG Volume (30 Days)
319.9K
★ 458.3K
Earning Date
08-14-2026
11-05-2026
Dividend Yield
N/A
★ 1.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$243.83
$23.53
Revenue Next Year
N/A
$10.89
P/E Ratio
★ N/A
$187.97
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$8.77
52 Week High
$17.25
$13.20

Technical Indicators

Market Signals
Indicator
ANL
LOMA
Relative Strength Index (RSI) 36.44 41.94
Support Level $8.96 $8.92
Resistance Level $12.49 $12.10
Average True Range (ATR) 1.30 0.36
MACD -0.29 -0.03
Stochastic Oscillator 5.98 21.23

Price Performance

Historical Comparison
ANL
LOMA

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The Group is engaged in the production and distribution of cement, masonry cement, concrete, limestone, and aggregates, operates a railway concession to provide transportation services, and is also engaged in the industrial waste recycling business. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

Share on Social Networks: